• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

4-(1-Ethylcyclobutyl)butan-1-amine (CAS No. 2151616-83-8): Properties, Applications, and Market Insights

4-(1-Ethylcyclobutyl)butan-1-amine (CAS No. 2151616-83-8) is a specialized organic compound that has garnered significant attention in the fields of pharmaceutical research and specialty chemicals. This unique amine derivative, characterized by its cyclobutyl and ethyl functional groups, offers a versatile scaffold for synthetic applications. Its molecular structure, C10H21N, provides a balance of lipophilicity and reactivity, making it a valuable intermediate in drug discovery and material science.

The compound's chemical properties include a molecular weight of 155.28 g/mol and a distinctive amine functionality that enables diverse chemical transformations. Researchers have explored its potential as a building block for bioactive molecules, particularly in the development of central nervous system (CNS) therapeutics. The ethylcyclobutyl moiety contributes to enhanced metabolic stability, a feature highly sought after in modern medicinal chemistry.

In recent years, 4-(1-ethylcyclobutyl)butan-1-amine has emerged as a subject of interest in AI-driven drug discovery platforms. Computational chemists frequently search for "novel amine scaffolds for drug design" or "cyclobutyl-containing building blocks," reflecting the growing demand for structurally diverse compounds in pharmaceutical R&D. The compound's unique spatial configuration makes it particularly valuable for addressing challenging biological targets, including G-protein-coupled receptors (GPCRs) and ion channels.

The synthesis of 2151616-83-8 typically involves multi-step organic transformations, with key steps including cyclobutane ring formation and subsequent amine functionalization. Process chemists have optimized routes to achieve high yields while maintaining excellent purity profiles, as evidenced by analytical data showing ≥98% purity in commercial samples. These advancements align with industry searches for "high-purity specialty amines" and "scalable synthetic routes for complex amines."

Market analysis reveals increasing demand for 4-(1-ethylcyclobutyl)butan-1-amine across several regions, particularly in North America and Asia-Pacific research hubs. Pharmaceutical companies frequently inquire about "custom synthesis of advanced amine intermediates" and "structure-activity relationship studies with cyclobutyl derivatives." The compound's price point reflects its specialized nature, typically commanding premium pricing in the fine chemicals market.

From an applications perspective, 2151616-83-8 has shown promise in multiple domains beyond pharmaceuticals. Materials scientists have investigated its potential as a monomer for specialty polymers, while agrochemical researchers explore its utility in crop protection agent development. These diverse applications contribute to its growing popularity in scientific literature and patent filings.

Quality control for 4-(1-ethylcyclobutyl)butan-1-amine follows stringent protocols, with characterization typically including NMR spectroscopy, mass spectrometry, and HPLC analysis. These analytical techniques address common researcher queries about "amine compound characterization methods" and "purity verification for building blocks." The compound's stability profile allows for standard storage conditions, typically at 2-8°C under inert atmosphere.

Recent scientific publications have highlighted innovative uses of cyclobutyl-containing amines in photopharmacology and targeted drug delivery systems. These cutting-edge applications align with trending searches for "next-generation drug delivery technologies" and "light-responsive pharmaceutical agents." The compound's structural features make it particularly suitable for these emerging fields.

From a regulatory standpoint, 4-(1-ethylcyclobutyl)butan-1-amine is not currently classified under restricted substance lists, making it accessible for research purposes worldwide. However, proper laboratory safety protocols should always be followed when handling any chemical substance, in line with institutional guidelines and good research practices.

The future outlook for 2151616-83-8 appears promising, with market analysts predicting steady growth in demand. This projection reflects broader trends in the specialty chemicals sector, where structurally unique intermediates continue to gain importance in advanced research applications. The compound's versatility ensures its relevance across multiple scientific disciplines for years to come.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)